000 01306 a2200349 4500
005 20250516194852.0
264 0 _c20150515
008 201505s 0 0 eng d
022 _a1098-6596
024 7 _a10.1128/AAC.02583-13
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMcGrath, Marieta
245 0 0 _aMoxifloxacin retains antimycobacterial activity in the presence of gyrA mutations.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cMay 2014
300 _a2912-5 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntitubercular Agents
_xpharmacology
650 0 4 _aBacterial Proteins
_xgenetics
650 0 4 _aDNA Gyrase
_xgenetics
650 0 4 _aDrug Resistance, Bacterial
_xgenetics
650 0 4 _aFluoroquinolones
_xpharmacology
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aMoxifloxacin
650 0 4 _aMutation
650 0 4 _aMycobacterium tuberculosis
_xdrug effects
700 1 _aGey van Pittius, Nico C
700 1 _aSirgel, Frederick A
700 1 _aVan Helden, Paul D
700 1 _aWarren, Robin M
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 58
_gno. 5
_gp. 2912-5
856 4 0 _uhttps://doi.org/10.1128/AAC.02583-13
_zAvailable from publisher's website
999 _c23532870
_d23532870